My Private Msgs
Biotech / Medical
-- Ignore unavailable to you. Want to
who wrote (
10/17/2001 4:30:02 AM
From the rights announcement in March -
"...PPL has recently been awarded a contract by DARPA for up to $3.1 million to support research involving the potential to produce large quantities of human polyclonal antibodies against a range of biological warfare agents, such as Anthrax and Ebola (amongst others). PPL retains the rights to commercialise all non-military applications of the technology, for example, in the potential treatment of diseases such as autoimmune disease, hepatitis, HIV and cancer..."
Copyright © 1995-2013 Knight Sac Media. All rights reserved.